Vilya, Inc. Founder and lead investor ARCH Venture Partners is joined by NVIDIA’s NVentures, Menlo Ventures, and Madrona. Funding accelerates advancement of Vilya's proprietary computational ...

Vilya Inc., which is based in Seattle but operates three-quarters of its staff out of South San Francisco, said Nvidia Corp.'s (Nasdaq: NVDA) NVentures venture capital arm, ...

Vilya, a biotech startup built off technology developed at the Seattle-based Institute for Protein Design, announced an expanded $71 million Series A investment round.. The 2-year-old company ...

Vilya is leveraging its platform to focus on previously difficult-to-drug therapeutic targets. Vilya was co-founded by a team of scientists from the Institute of Protein Design (IPD) led by David ...

Vilya. By Rick Morgan – Inno Senior Reporter, Puget Sound Business Journal. Jun 10, 2024. Preview this article 1 min. CEO Cyrus Harmon says the funding is an important stepping stone for the ...

Vilya says it will license the platform and molecules described in the Cell research paper, and has raised $50 million in Series A financing from a group of investors led by Arch Venture Partners.

– License of proprietary RFdiffusion-based model, RFpeptides, provides Vilya with another powerful structure prediction framework for rapid and unique design of potent and selective macrocycles ...

In April, Vilya researchers published a paper showing that they had used their computational platform to design 15 million potential macrocycles using amino acids beyond the 20 natural ones ...

Vilya, the Ring of Air, is the mightiest of the Three Elven Rings, as worn by Elrond in LOTR. The Three Rings grant powers to heal, preserve beauty, and enhance traits of their bearers.

– License of proprietary RFdiffusion-based model, RFpeptides, provides Vilya with another powerful structure prediction framework for rapid and unique design of potent and selective macrocycles ...